Renal Syndrome Articles & Analysis: Older

1 articles found

Safety and immunogenicity of bivalent inactivated vaccine against haemorrhagic fever with renal syndrome in a phase II trial on healthy Chinese volunteers

We have developed a cell culture-derived, inactivated bivalent vaccine against both Haemorrhagic Fever with Renal Syndrome (HFRS) viruses 84 Fli (type I) and L99 (type II). This purified vaccine was tested in the clinical phase I/II trial in healthy non-infected adults in China. ...

Jun. 28, 2007

ByInderscience Publishers

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you